Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

NCT01790035 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Gastrointestinal Neoplasms

Interventions

DRUG: LGG
DRUG: Placebo

Sponsor

Washington University School of Medicine